351 related articles for article (PubMed ID: 18723296)
21. A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinoma.
Johnson FM; Garden AS; Palmer JL; Shin DM; Morrison W; Papadimitrakopoulou V; Khuri F; Clayman G; Goepfert H; Ang KK; Hong WK; Glisson BS
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):717-24. PubMed ID: 16199307
[TBL] [Abstract][Full Text] [Related]
22. Concurrent chemoradiotherapy in locoregionally recurrent nasopharyngeal carcinoma.
Poon D; Yap SP; Wong ZW; Cheung YB; Leong SS; Wee J; Tan T; Fong KW; Chua ET; Tan EH
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1312-8. PubMed ID: 15275714
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for severe Dysphagia after concurrent chemoradiotherapy for head and neck cancers.
Koiwai K; Shikama N; Sasaki S; Shinoda A; Kadoya M
Jpn J Clin Oncol; 2009 Jul; 39(7):413-7. PubMed ID: 19383615
[TBL] [Abstract][Full Text] [Related]
24. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.
Valentini V; Coco C; Minsky BD; Gambacorta MA; Cosimelli M; Bellavita R; Morganti AG; La Torre G; Trodella L; Genovesi D; Portaluri M; Maurizi-Enrici R; Barbera F; Maranzano E; Lupattelli M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):403-12. PubMed ID: 17919844
[TBL] [Abstract][Full Text] [Related]
25. 'Boomerang' technique: an improved method for conformal treatment of locally advanced nasopharyngeal cancer.
Corry J; Hornby C; Fisher R; D'Costa I; Porceddu S; Rischin D; Peters LJ
Australas Radiol; 2004 Jun; 48(2):170-80. PubMed ID: 15230751
[TBL] [Abstract][Full Text] [Related]
26. [Prognostic factors in nasopharyngeal carcinoma in childhood and adolescence].
Cao KJ; Li Y; Xie GF; Hong MH
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):134-7. PubMed ID: 16750020
[TBL] [Abstract][Full Text] [Related]
27. SMART (simultaneous modulated accelerated radiotherapy) for locally advanced nasopharyngeal carcinomas.
Koom WS; Kim TH; Shin KH; Pyo HR; Kim JY; Kim DY; Yoon M; Park SY; Lee DH; Ryu JS; Jung YS; Lee SH; Cho KH
Head Neck; 2008 Feb; 30(2):159-69. PubMed ID: 17764088
[TBL] [Abstract][Full Text] [Related]
28. Nasopharyngeal carcinoma in children: comparison of conventional and intensity-modulated radiotherapy.
Laskar S; Bahl G; Muckaden M; Pai SK; Gupta T; Banavali S; Arora B; Sharma D; Kurkure PA; Ramadwar M; Viswanathan S; Rangarajan V; Qureshi S; Deshpande DD; Shrivastava SK; Dinshaw KA
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):728-36. PubMed ID: 18374512
[TBL] [Abstract][Full Text] [Related]
29. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
[TBL] [Abstract][Full Text] [Related]
30. Conformal therapy improves the therapeutic index of patients with anal canal cancer treated with combined chemotherapy and external beam radiotherapy.
Vuong T; Kopek N; Ducruet T; Portelance L; Faria S; Bahoric B; Devic S
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1394-400. PubMed ID: 17276620
[TBL] [Abstract][Full Text] [Related]
31. Radiation therapy with UFT and low dose weekly cisplatin for nasopharyngeal carcinoma.
Park JH; Nam SY; Lee SW; Kim SB; Kim SY; Lee BJ; Cho KJ; Kim JH; Ahn SD; Shin SS; Choi SH; Ahn JH; Choi EK
Auris Nasus Larynx; 2005 Mar; 32(1):43-8. PubMed ID: 15882825
[TBL] [Abstract][Full Text] [Related]
32. Results of combined modality treatment for nasopharyngeal cancer.
Venkitaraman R; Ramanan SG; Vasanthan A; Sagar TG
J Cancer Res Ther; 2009; 5(2):102-6. PubMed ID: 19542665
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy.
Wei X; Liu HH; Tucker SL; Liao Z; Hu C; Mohan R; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):100-7. PubMed ID: 16839700
[TBL] [Abstract][Full Text] [Related]
34. Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for recurrence and survival rate.
Chu ST; Wu PH; Chou P; Lee CC
Eur Arch Otorhinolaryngol; 2008 Jul; 265 Suppl 1():S115-20. PubMed ID: 18236065
[TBL] [Abstract][Full Text] [Related]
35. [Concomitant chemo-radiotherapy for locoregionally advanced nasopharygeal carcinoma].
Tian Y; Chua DT; Sham JS
Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):429-31. PubMed ID: 16188131
[TBL] [Abstract][Full Text] [Related]
36. Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma.
Hara W; Loo BW; Goffinet DR; Chang SD; Adler JR; Pinto HA; Fee WE; Kaplan MJ; Fischbein NJ; Le QT
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):393-400. PubMed ID: 18164839
[TBL] [Abstract][Full Text] [Related]
37. Treatment results of alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil--a phase II study.
Fuwa N; Shikama N; Hayashi N; Matsuzuka T; Toita T; Yuta A; Oonishi H; Kodaira T; Tachibana H; Nakamura T; Daimon T
Oral Oncol; 2007 Oct; 43(9):948-55. PubMed ID: 17257880
[TBL] [Abstract][Full Text] [Related]
38. Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for early breast carcinoma.
Livi L; Saieva C; Borghesi S; Paoletti L; Meattini I; Rampini A; Petrucci A; Scoccianti S; Paiar F; Cataliotti L; Leonulli BG; Bianchi S; Biti GP
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):705-9. PubMed ID: 18191333
[TBL] [Abstract][Full Text] [Related]
39. Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma.
Morota M; Gomi K; Kozuka T; Chin K; Matsuura M; Oguchi M; Ito H; Yamashita T
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):122-8. PubMed ID: 19327900
[TBL] [Abstract][Full Text] [Related]
40. Hyperfractionated radiation therapy for locoregionally advanced nasopharyngeal cancer.
Isobe K; Uno T; Kawakami H; Ueno N; Aruga T; Yasuda S; Hanazawa T; Okamoto Y; Ito H; Shigematsu N
Jpn J Clin Oncol; 2005 Mar; 35(3):116-20. PubMed ID: 15741300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
